Acute Coronary Syndromes
Metabolic syndrome in throes of AMI often confirmed later and may up risk by itself
2 COMMENT S - Apr 26, 2013 17:00 EDT
It's never been clear whether the telltale metabolic signs at hospitalization tell the same prognostic story as in the outpatient setting. Certainly it wasn't known whether they had their own story to tell.

Vienna, Austria - About two-thirds of patients with acute MI qualify for a diagnosis of metabolic syndrome while they are still in the hospital, and despite concerns that the telltale metabolic markers can be deceptively skewed that close to the acute phase, usually the diagnosis can be confirmed a month later, suggests a prospective registry study [1].

That suggests a metabolic-syndrome diagnosis in the acute setting that does not hold up later may still be prognostic in its own right, observed Dr Suzanne V Arnold (Saint Luke Mid America Heart Institute, Kansas City, MO) when presenting the analysis here at the Prediabetes and the Metabolic Syndrome 2013 Congress. And that, she said, supports the practice of screening MI patients for metabolic syndrome and making a diagnosis while they are still in the hospital.
Read full article »

Lipid/Metabolic
Dietary saturated fat has undeserved bad reputation, says review
May 17, 2013 16:45 EDT

Prevention
Never too old to get moving: Aerobic fitness lowers risk of death in elderly
May 17, 2013 10:30 EDT

Lipid/Metabolic
Hormone therapy associated with MI in male-to-female transsexuals
May 14, 2013 14:00 EDT

Lipid/Metabolic
Simple tool stratifies mortality risk in type 2 diabetes
May 13, 2013 14:15 EDT

Prevention
No benefit of fish oil in high-risk patients
May 8, 2013 17:00 EDT

Lipid/Metabolic
Diabetes increases stroke risk, particularly in under-65s
May 6, 2013 16:00 EDT

Editorial programs
Debate and dialogue between top cardiovascular specialists, produced by
theheart.org's editorial team
View all »
Healthcare reform and cardiology: An even-keeled update
Healthcare reform and cardiology: An even-keeled update
May 2, 2013 08:45 EDT
Breaking embargo: PREVAIL and how we publish data from clinical trials
Breaking embargo: PREVAIL and how we publish data from clinical trials
Apr 12, 2013 16:33 EDT
ACC 2013 research highlights: A slideshow presentation
ACC 2013 research highlights: A slideshow presentation
4 COMMENTS - Mar 19, 2013 10:00 EDT
View all »Collections
heartwire collections groups our most compelling cardiology news coverage and editorial content by popular themes. Find everything on a single topic, in one place, with one click.
Rosiglitazone wrangling
A controversial 2007 meta-analysis questioning the cardiovascular safety of...
Omega-3 fatty acids and cardiovascular disease
Randomized clinical trials dating back to the GISSI Prevenzione study have cemented a...
Low-carb vs low-fat diets
Low-carb diets like Atkins and South Beach have, in some studies, shown...
Vitamin D and the heart
A growing body of evidence is linking low levels of serum vitamin D to a range of...
The SHAPE guidelines
Back in July 2006, some of the biggest names in cardiology signed their name to the...
View all »
Other Programs
Resource Center (view all)

What's New